Dynavax Technologies Corp (NAS:DVAX)
$ 12.97 -0.06 (-0.46%) Market Cap: 1.71 Bil Enterprise Value: 1.17 Bil PE Ratio: 100.23 PB Ratio: 2.51 GF Score: 70/100

Q2 2022 Dynavax Technologies Corp Earnings Call Transcript

Aug 04, 2022 / 08:30PM GMT
Release Date Price: $14.34 (+1.49%)
Operator

Good day, and welcome to the Dynavax Technologies Second Quarter 2022 Financial Results Call. As a reminder, this conference call is being recorded. (Operator Instructions) I would now like to turn the call over to Nicole Arndt, Senior Manager for Investor Relations. You may begin.

Nicole Arndt
Dynavax Technologies Corporation - Senior Manager of IR

Thank you. Good afternoon, and welcome to the Dynavax Second Quarter 2022 Financial Results and Corporate Update Conference Call. In addition to our press release issued today, a supplementary slide presentation that accompanies today's call is available in the Events section of our website.

Before we begin, I advise you that we will be making forward-looking statements today based on our current expectations and beliefs, including, but not limited to potential market sizes and market share; market trends; impact of ACIP recommendations and timing of such impact; financial guidance and trends, including revenue, profitability and sufficiency of current capitalization; timing and results of clinical trial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot